CareLit Fachartikel

Verapamil enhances the antiproliferative effect of chemotherapeutic reagents and inhibits tumor growth of chemoresistant side population in pancreatic cancer

L Zhao, Y Zhao, B Schwarz, J Mysliwietz, P Camaj, Q Bao, JW Jauch, PJ Nelson, M Guba, JW Ellwart, CJ Bruns, AG Bruns · Zeitschrift für Gastroenterologie · 2012 · Heft 08

Dokument
980560
CareLit-ID
Jahr
2012
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
L Zhao, Y Zhao, B Schwarz, J Mysliwietz, P Camaj, Q Bao, JW Jauch, PJ Nelson, M Guba, JW Ellwart, CJ Bruns, AG Bruns
Ausgabe
Heft 08 / 2012
Seiten
–
Erschienen: 2012-08-22 00:00:00
ISSN
0044-2771

Zusammenfassung

Introduction: Verapamil is an L-type calcium channel blocker and has been used in the treatment of hypertension, angina pectoris, cardiac arrhythmia, and most recently, cluster headaches. Increasing evidence shows that Verapamil is able to enhance the cytotoxic effect of certain chemotherapies and reverse multidrug resistance by competitively inhibiting drug transport through P-glycoprotein. The side population (SP) is a small subtype of tumor cells with stem-like properties which could substantially be blocked by verapamil. In this study, we focus on the therapeutic potential of verapamil on stem-like SP cells…

Schlagworte

Zeitschrift für Gastroenterologie